Companies / T-Cypher Bio
T-Cypher Bio
Abingdon, United Kingdom
T-Cypher Bio develops drugs against novel disease-specific targets to improve the lives of patients with cancer and autoimmune diseases.
T-Cypher Bio, based in Abingdon, United Kingdom, has 5 investors on file, among them Future Planet Capital, LifeArc Ventures and Oxford Investment Consultants. Its site was last checked 6 Nov 2026: site answers.
Investors
5 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Corporate VC | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Investor |
In the news
2 headlines naming T-Cypher BioEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get T-Cypher Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Future Planet Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/tcypherbio.com/investors
# also
GET /v1/companies/tcypherbio.com
GET /v1/companies/tcypherbio.com/news